Citigroup Inc Beam Therapeutics Inc. Put Options Transaction History

Citigroup Inc

  • $150 Billion
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 10, 2024
BUY
$23.46 - $45.07 $586,500 - $1.13 Million
25,000 Added 100.4%
49,900 $1.65 Million
Q4 2023

Feb 09, 2024
BUY
$17.69 - $30.76 $440,481 - $765,924
24,900 New
24,900 $677,000
Q1 2023

May 11, 2023
BUY
$30.15 - $48.79 $48,240 - $78,064
1,600 Added 10.06%
17,500 $535,000
Q4 2022

Feb 09, 2023
BUY
$36.73 - $51.6 $584,007 - $820,440
15,900 New
15,900 $621,000

Others Institutions Holding BEAM

# of Institutions
241
Shares Held
65.6M
Call Options Held
311K
Put Options Held
777K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.59B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email